Use of Trimetazidine in the Combined Therapy of Myocardial Infarction with Left Ventricular Disfunction

Terestchenko S.N.¹ , Alexandria L.G.¹ , Moiseev V.S.¹

КАРДИОЛОГИЯ

KlinMed Consulting

10

Русский

19-21

Опубликовано

Внешняя ссылка

42

2002

• ¹ Russia Univ. of Friendship People, Vavilova, 61, 117292 Moscow, Russian Federation

acetylsalicylic acid; anticoagulant agent; antithrombocytic agent; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; fibrinolytic agent; glyceryl trinitrate; heparin; trimetazidine; vasodilator agent; article; clinical trial; comparative study; controlled clinical trial; controlled study; Doppler echocardiography; drug combination; echocardiography; female; fibrinolytic therapy; follow up; heart infarction; heart left ventricle function; heart ventricle remodeling; hemodynamics; human; intravenous drug administration; male; middle aged; pathophysiology; randomized controlled trial; time; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diuretics; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Fibrinolytic Agents; Follow-Up Studies; Hemodynamic Processes; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling